{
  "fullName": "Özlem Türeci",
  "slug": "ozlem-tureci",
  "title": "MD",
  "specialty": "NTech",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 26.8,
  "hIndex": 80,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Özlem Türeci is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief medical officer since 2018. Since 2021, she has been Professor of Personalized Immunotherapy at the Helmholtz Institute for Translational Oncology (HI-TRON) and Johannes Gutenberg University Mainz. Türeci and her spouse, Uğur Şahin, have won a number of awards.",
  "aiSummary": "Oncology",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Bio"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Bio",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "NTech"
  ],
  "knowsAbout": [
    "Oncology"
  ],
  "citations": [
    {
      "title": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine",
      "journal": "New England Journal of Medicine",
      "year": 2020,
      "citationCount": 15106,
      "doi": "10.1056/nejmoa2034577",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2034577",
      "verified": true
    },
    {
      "title": "Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates",
      "journal": "New England Journal of Medicine",
      "year": 2020,
      "citationCount": 2683,
      "doi": "10.1056/nejmoa2027906",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2027906",
      "verified": true
    },
    {
      "title": "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer",
      "journal": "Nature",
      "year": 2017,
      "citationCount": 2347,
      "doi": "10.1038/nature23003",
      "sourceUrl": "https://doi.org/10.1038/nature23003",
      "verified": true
    },
    {
      "title": "mRNA-based therapeutics — developing a new class of drugs",
      "journal": "Nature Reviews Drug Discovery",
      "year": 2014,
      "citationCount": 2292,
      "doi": "10.1038/nrd4278",
      "sourceUrl": "https://doi.org/10.1038/nrd4278",
      "verified": true
    },
    {
      "title": "COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses",
      "journal": "Nature",
      "year": 2020,
      "citationCount": 2004,
      "doi": "10.1038/s41586-020-2814-7",
      "sourceUrl": "https://doi.org/10.1038/s41586-020-2814-7",
      "verified": true
    },
    {
      "title": "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy",
      "journal": "Nature",
      "year": 2016,
      "citationCount": 1668,
      "doi": "10.1038/nature18300",
      "sourceUrl": "https://doi.org/10.1038/nature18300",
      "verified": true
    },
    {
      "title": "Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults",
      "journal": "Nature",
      "year": 2020,
      "citationCount": 1565,
      "doi": "10.1038/s41586-020-2639-4",
      "sourceUrl": "https://doi.org/10.1038/s41586-020-2639-4",
      "verified": true
    },
    {
      "title": "A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 1997,
      "citationCount": 1234,
      "doi": "10.1073/pnas.94.5.1914",
      "sourceUrl": "https://doi.org/10.1073/pnas.94.5.1914",
      "verified": true
    },
    {
      "title": "Mutant MHC class II epitopes drive therapeutic immune responses to cancer",
      "journal": "Nature",
      "year": 2015,
      "citationCount": 1210,
      "doi": "10.1038/nature14426",
      "sourceUrl": "https://doi.org/10.1038/nature14426",
      "verified": true
    },
    {
      "title": "Personalized vaccines for cancer immunotherapy",
      "journal": "Science",
      "year": 2018,
      "citationCount": 1061,
      "doi": "10.1126/science.aar7112",
      "sourceUrl": "https://doi.org/10.1126/science.aar7112",
      "verified": true
    },
    {
      "title": "Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.",
      "journal": "Nature",
      "year": 2023,
      "citationCount": 1053,
      "doi": "10.1038/s41586-023-06063-y",
      "sourceUrl": "https://doi.org/10.1038/s41586-023-06063-y",
      "verified": true
    },
    {
      "title": "An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma",
      "journal": "Nature",
      "year": 2020,
      "citationCount": 958,
      "doi": "10.1038/s41586-020-2537-9",
      "sourceUrl": "https://doi.org/10.1038/s41586-020-2537-9",
      "verified": true
    },
    {
      "title": "Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents",
      "journal": "New England Journal of Medicine",
      "year": 2021,
      "citationCount": 912,
      "doi": "10.1056/nejmoa2107456",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2107456",
      "verified": true
    },
    {
      "title": "Exploiting the Mutanome for Tumor Vaccination",
      "journal": "Cancer Research",
      "year": 2012,
      "citationCount": 811,
      "doi": "10.1158/0008-5472.can-11-3722",
      "sourceUrl": "https://doi.org/10.1158/0008-5472.can-11-3722",
      "verified": true
    },
    {
      "title": "BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans",
      "journal": "Nature",
      "year": 2021,
      "citationCount": 809,
      "doi": "10.1038/s41586-021-03653-6",
      "sourceUrl": "https://doi.org/10.1038/s41586-021-03653-6",
      "verified": true
    },
    {
      "title": "BNT162b vaccines protect rhesus macaques from SARS-CoV-2",
      "journal": "Nature",
      "year": 2021,
      "citationCount": 721,
      "doi": "10.1038/s41586-021-03275-y",
      "sourceUrl": "https://doi.org/10.1038/s41586-021-03275-y",
      "verified": true
    },
    {
      "title": "Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age",
      "journal": "New England Journal of Medicine",
      "year": 2021,
      "citationCount": 611,
      "doi": "10.1056/nejmoa2116298",
      "sourceUrl": "https://doi.org/10.1056/nejmoa2116298",
      "verified": true
    },
    {
      "title": "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells",
      "journal": "Blood",
      "year": 2006,
      "citationCount": 588,
      "doi": "10.1182/blood-2006-04-015024",
      "sourceUrl": "https://doi.org/10.1182/blood-2006-04-015024",
      "verified": true
    },
    {
      "title": "Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera",
      "journal": "Science",
      "year": 2021,
      "citationCount": 551,
      "doi": "10.1126/science.abg6105",
      "sourceUrl": "https://doi.org/10.1126/science.abg6105",
      "verified": true
    },
    {
      "title": "Identification of neoantigens for individualized therapeutic cancer vaccines",
      "journal": "Nature Reviews Drug Discovery",
      "year": 2022,
      "citationCount": 529,
      "doi": "10.1038/s41573-021-00387-y",
      "sourceUrl": "https://doi.org/10.1038/s41573-021-00387-y",
      "verified": true
    },
    {
      "title": "An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors",
      "journal": "Science",
      "year": 2020,
      "citationCount": 475,
      "doi": "10.1126/science.aay5967",
      "sourceUrl": "https://doi.org/10.1126/science.aay5967",
      "verified": true
    },
    {
      "title": "A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis",
      "journal": "Science",
      "year": 2021,
      "citationCount": 451,
      "doi": "10.1126/science.aay3638",
      "sourceUrl": "https://doi.org/10.1126/science.aay3638",
      "verified": true
    },
    {
      "title": "Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development",
      "journal": "Clinical Cancer Research",
      "year": 2008,
      "citationCount": 431,
      "doi": "10.1158/1078-0432.ccr-08-1547",
      "sourceUrl": "https://doi.org/10.1158/1078-0432.ccr-08-1547",
      "verified": true
    },
    {
      "title": "SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3",
      "journal": "New England Journal of Medicine",
      "year": 2021,
      "citationCount": 414,
      "doi": "10.1056/nejmc2113468",
      "sourceUrl": "https://doi.org/10.1056/nejmc2113468",
      "verified": true
    },
    {
      "title": "Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera",
      "journal": "Science",
      "year": 2022,
      "citationCount": 379,
      "doi": "10.1126/science.abn7591",
      "sourceUrl": "https://doi.org/10.1126/science.abn7591",
      "verified": true
    },
    {
      "title": "Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma",
      "journal": "BMC Genomics",
      "year": 2014,
      "citationCount": 373,
      "doi": "10.1186/1471-2164-15-190",
      "sourceUrl": "https://doi.org/10.1186/1471-2164-15-190",
      "verified": true
    },
    {
      "title": "Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 1998,
      "citationCount": 357,
      "doi": "10.1073/pnas.95.13.7608",
      "sourceUrl": "https://doi.org/10.1073/pnas.95.13.7608",
      "verified": true
    },
    {
      "title": "mRNA therapeutics in cancer immunotherapy",
      "journal": "Molecular Cancer",
      "year": 2021,
      "citationCount": 354,
      "doi": "10.1186/s12943-021-01348-0",
      "sourceUrl": "https://doi.org/10.1186/s12943-021-01348-0",
      "verified": true
    },
    {
      "title": "Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3′ UTRs Identified by Cellular Library Screening",
      "journal": "Molecular Therapy",
      "year": 2018,
      "citationCount": 337,
      "doi": "10.1016/j.ymthe.2018.12.011",
      "sourceUrl": "https://doi.org/10.1016/j.ymthe.2018.12.011",
      "verified": true
    },
    {
      "title": "Autoantibodies in lung cancer: possibilities for early detection and subsequent cure",
      "journal": "Thorax",
      "year": 2007,
      "citationCount": 335,
      "doi": "10.1136/thx.2007.083592",
      "sourceUrl": "https://doi.org/10.1136/thx.2007.083592",
      "verified": true
    },
    {
      "title": "Characterization of human colon cancer antigens recognized by autologous antibodies",
      "journal": "International Journal of Cancer",
      "year": 1998,
      "citationCount": 329,
      "doi": "10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p",
      "sourceUrl": "https://doi.org/10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p",
      "verified": true
    },
    {
      "title": "Serological identification of human tumor antigens",
      "journal": "Current Opinion in Immunology",
      "year": 1997,
      "citationCount": 314,
      "doi": "10.1016/s0952-7915(97)80053-2",
      "sourceUrl": "https://doi.org/10.1016/s0952-7915(97)80053-2",
      "verified": true
    },
    {
      "title": "Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity",
      "journal": "Cancer Research",
      "year": 2010,
      "citationCount": 304,
      "doi": "10.1158/0008-5472.can-10-0699",
      "sourceUrl": "https://doi.org/10.1158/0008-5472.can-10-0699",
      "verified": true
    },
    {
      "title": "HLA typing from RNA-Seq sequence reads",
      "journal": "Genome Medicine",
      "year": 2012,
      "citationCount": 300,
      "doi": "10.1186/gm403",
      "sourceUrl": "https://doi.org/10.1186/gm403",
      "verified": true
    },
    {
      "title": "Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 1998,
      "citationCount": 279,
      "doi": "10.1073/pnas.95.9.5211",
      "sourceUrl": "https://doi.org/10.1073/pnas.95.9.5211",
      "verified": true
    },
    {
      "title": "Elimination of large tumors in mice by mRNA-encoded bispecific antibodies",
      "journal": "Nature Medicine",
      "year": 2017,
      "citationCount": 266,
      "doi": "10.1038/nm.4356",
      "sourceUrl": "https://doi.org/10.1038/nm.4356",
      "verified": true
    },
    {
      "title": "Molecular Definition of a Novel Human Galectin Which Is Immunogenic in Patients with Hodgkin's Disease",
      "journal": "Journal of Biological Chemistry",
      "year": 1997,
      "citationCount": 250,
      "doi": "10.1074/jbc.272.10.6416",
      "sourceUrl": "https://doi.org/10.1074/jbc.272.10.6416",
      "verified": true
    },
    {
      "title": "SSX: A multigene family with several members transcribed in normal testis and human cancer",
      "journal": "International Journal of Cancer",
      "year": 1997,
      "citationCount": 239,
      "doi": "10.1002/(sici)1097-0215(19970917)72:6<965::aid-ijc8>3.0.co;2-n",
      "sourceUrl": "https://doi.org/10.1002/(sici)1097-0215(19970917)72:6<965::aid-ijc8>3.0.co;2-n",
      "verified": true
    },
    {
      "title": "Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo",
      "journal": "Gene Therapy",
      "year": 2010,
      "citationCount": 214,
      "doi": "10.1038/gt.2010.52",
      "sourceUrl": "https://doi.org/10.1038/gt.2010.52",
      "verified": true
    },
    {
      "title": "Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals",
      "journal": "The Journal of Immunology",
      "year": 2008,
      "citationCount": 212,
      "doi": "10.4049/jimmunol.180.1.309",
      "sourceUrl": "https://doi.org/10.4049/jimmunol.180.1.309",
      "verified": true
    },
    {
      "title": "CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.",
      "journal": "Nature medicine",
      "year": 2023,
      "citationCount": 210,
      "doi": "10.1038/s41591-023-02612-0",
      "sourceUrl": "https://doi.org/10.1038/s41591-023-02612-0",
      "verified": true
    },
    {
      "title": "The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines",
      "journal": "mBio",
      "year": 2022,
      "citationCount": 196,
      "doi": "10.1128/mbio.02979-21",
      "sourceUrl": "https://doi.org/10.1128/mbio.02979-21",
      "verified": true
    },
    {
      "title": "Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.",
      "journal": "Science immunology",
      "year": 2022,
      "citationCount": 195,
      "doi": "10.1126/sciimmunol.abq2427",
      "sourceUrl": "https://doi.org/10.1126/sciimmunol.abq2427",
      "verified": true
    },
    {
      "title": "The Human Vaccines Project: A roadmap for cancer vaccine development",
      "journal": "Science Translational Medicine",
      "year": 2016,
      "citationCount": 190,
      "doi": "10.1126/scitranslmed.aaf0685",
      "sourceUrl": "https://doi.org/10.1126/scitranslmed.aaf0685",
      "verified": true
    },
    {
      "title": "A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity",
      "journal": "Molecular Therapy",
      "year": 2019,
      "citationCount": 186,
      "doi": "10.1016/j.ymthe.2019.09.009",
      "sourceUrl": "https://doi.org/10.1016/j.ymthe.2019.09.009",
      "verified": true
    },
    {
      "title": "Selective uptake of naked vaccine RNA by dendritic cells is driven by macropinocytosis and abrogated upon DC maturation",
      "journal": "Gene Therapy",
      "year": 2011,
      "citationCount": 185,
      "doi": "10.1038/gt.2011.17",
      "sourceUrl": "https://doi.org/10.1038/gt.2011.17",
      "verified": true
    },
    {
      "title": "Expression ofSSX genes in human tumors",
      "journal": "International Journal of Cancer",
      "year": 1998,
      "citationCount": 179,
      "doi": "10.1002/(sici)1097-0215(19980703)77:1<19::aid-ijc4>3.0.co;2-2",
      "sourceUrl": "https://doi.org/10.1002/(sici)1097-0215(19980703)77:1<19::aid-ijc4>3.0.co;2-2",
      "verified": true
    },
    {
      "title": "BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans",
      "journal": "Unknown Journal",
      "year": 2020,
      "citationCount": 171,
      "doi": "10.1101/2020.12.09.20245175",
      "sourceUrl": "https://doi.org/10.1101/2020.12.09.20245175",
      "verified": true
    },
    {
      "title": "RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer.",
      "journal": "Nature",
      "year": 2025,
      "citationCount": 155,
      "doi": "10.1038/s41586-024-08508-4",
      "sourceUrl": "https://doi.org/10.1038/s41586-024-08508-4",
      "verified": true
    },
    {
      "title": "RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study",
      "journal": "Unknown Journal",
      "year": 2020,
      "citationCount": 155,
      "doi": "10.1101/2020.08.17.20176651",
      "sourceUrl": "https://doi.org/10.1101/2020.08.17.20176651",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/9/90/Ozlem_Tureci_v1.jpg/330px-Ozlem_Tureci_v1.jpg",
  "openalexId": "https://openalex.org/A5000036560"
}